A team led by Lauren Ehrlich found a link between myeloid cells and the cancer that often strikes children.

Drug candidate developed by Everett Stone and his team is effective in mice with cancers of skin, bladder, blood and colon.

Kyle Miller and his team discovered a potential new target for drug therapies: structures in our DNA called R-loops.

Hong Qiao, a plant researcher, explains the science behind produce ripening, and how anyone can prolong shelf life.

The earliest stages of developing life have been, in many ways, a black box for researchers before now.

Every year, millions of people become sickened by RSV, and more than 100,000 die. New vaccines with a connection to UT Austin may help turn those numbers around.

Several graduating seniors from CNS have been recognized for their distinctive accomplishments, including the three individuals highlighted here.

A biologist at UT Austin who played a key role in the development of COVID-19 and RSV vaccines has received honors for the far-reaching impact of his research.

Dozens of graduate and undergraduate students of UT Austin's College of Natural Sciences were honored this year by the National Science Foundation.

Alone, this target might not be strong enough to directly block infection, but might be used to jump-start or boost an immune response.